| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $1,264,726 ) |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R01EB028848 | Treating Primary aldosteronism-induced hypertension via microwave thermal therapy | 000 | 4 | NIH | 3/13/2023 | $336,036 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R35GM140852 | Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci | 000 | 3 | NIH | 3/7/2023 | $363,312 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R01AR060788 | Mechanisms Underlying Muscle Development and Maintenance in Drosophila | 000 | 10 | NIH | 12/22/2022 | $294,125 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | T35OD029981 | Short Term Training in Health Professional Schools | 001 | 3 | NIH | 2/22/2023 | $2,035 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | T35OD029981 | Short Term Training in Health Professional Schools | 000 | 3 | NIH | 2/2/2023 | $66,424 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R34MH126043 | Physical Activity to Reduce Cardiometabolic Risk in Adults with Serious Mental Illness (PARCS Study) | 000 | 2 | NIH | 2/23/2023 | $223,820 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R01NS112506 | Molecular regulation of LRRK2 in Parkinson's disease | 001 | 4 | NIH | 1/31/2023 | $35,875 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R01NS112506 | Molecular regulation of LRRK2 in Parkinson's disease | 000 | 4 | NIH | 1/17/2023 | $322,875 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R03MH133173 | Understanding the role of the frontal cortex during cognitive flexibility in Fmr1 knock outs | 000 | 1 | NIH | 2/24/2023 | $71,819 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | F31HL167618 | ROLE OF ANGIOTENSIN-(1-7) AND DIAPHRAGM VASCULAR FUNCTION IN HEART FAILURE AND PROLONGED MECHANICAL VENTILATION | 001 | 1 | NIH | 12/26/2022 | $0 |
| | 2023 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | F31HL167618 | ROLE OF ANGIOTENSIN-(1-7) AND DIAPHRAGM VASCULAR FUNCTION IN HEART FAILURE AND PROLONGED MECHANICAL VENTILATION | 000 | 1 | NIH | 12/26/2022 | $34,538 |
| | 2023 | 2022 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | 90AK0083 | #RelationshipGoals-Beyond Just Talking: A Comprehensive PREP Program | 01 | 2 | ACF | 3/17/2023 | $0 |
| | 2023 | 2022 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | U01FD007132 | Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens in Kansas as a Part of the National Antimicrobial Resistance Monitoring System | 000 | 3 | FDA | 2/24/2023 | $0 |
| | 2023 | 2022 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | P20GM130448 | Center on Emerging and Zoonotic Infectious Diseases | 000 | 3 | NIH | 3/23/2023 | $0 |
| | 2023 | 2022 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | T5246763 | Public Health Scholarship Program | 01 | 1 | HRSA | 10/12/2022 | $0 |
| | 2023 | 2020 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | U18FD006990 | Prototype Reporting and Veterinarian and Animal Owner Educational Materials for Cases of Antimicrobial Resistant Bacteria of Public Health Importance in Companion Animals | 000 | 1 | FDA | 12/23/2022 | $0 |
| | 2023 | 2020 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | F31HL154779 | Mechanistic bases for the exaggerated mechanoreflex in peripheral arterial disease | 000 | 1 | NIH | 11/23/2022 | $0 |
| | 2023 | 2020 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R15CA242057 | HPV Oncogenes Dysregulate Translesion Synthesis | 000 | 1 | NIH | 3/9/2023 | $0 |
| | 2023 | 2020 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | U01FD006803 | Evaluation of chlortetracycline-treatment timing on the duration of treatment of bovine anaplasmosis in adult cattle | 000 | 2 | FDA | 2/14/2023 | $0 |
| | 2023 | 2020 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R01CA217657 | Rapid Protease Profiling with a Multiplex Electronic Method for Detection of Metastatic Triple-Negative Breast Cancer | 000 | 4 | NIH | 12/2/2022 | $0 |
| | 2023 | 2020 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R25GM119968 | Kansas Bridges to the Future | 001 | 5 | NIH | 10/26/2022 | -$266,683 |
| | 2023 | 2019 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R25GM119968 | Kansas Bridges to the Future | 000 | 4 | NIH | 10/26/2022 | -$185,380 |
| | 2023 | 2019 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | T32OD011169 | BRITE Veterinary Student Program | 000 | 16 | NIH | 10/1/2022 | -$32,753 |
| | 2023 | 2019 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | U01FD006804 | Defining targeted durations of use for tylosin phosphate to prevent liver abscess formation in feedlot cattle | 000 | 1 | FDA | 10/18/2022 | $0 |
| | 2023 | 2019 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | S10OD026726 | Console Upgrade and Cryogenic Probe for a 500 MHz NMR System for Biomedical Research | 000 | 1 | NIH | 10/20/2022 | $0 |
| | 2023 | 2018 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | T32OD011169 | BRITE Veterinary Student Program | 001 | 15 | NIH | 11/21/2022 | -$811 |
| | 2023 | 2017 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-1103 | RILEY | USA | R15CA219919 | Cancer-targeted local pulmonary immunotherapy with PD-L1 inhibitory peptide secretory genes for the treatment of lung cancer | 000 | 1 | NIH | 10/1/2022 | -$506 |
|
| Issue Date FY: 2022 ( Subtotal = $16,337,177 ) (Continued on the next page) |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R35GM141859 | Function of hemolymph plasma proteins in insect immune responses | 002 | 2 | NIH | 6/23/2022 | $37,671 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | P20GM130448 | Center on Emerging and Zoonotic Infectious Diseases | 001 | 3 | NIH | 6/10/2022 | $2,263,387 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01AI152418 | Vaccines Against Ehrlichia and Anaplasma Species Infections | 000 | 3 | NIH | 6/3/2022 | $622,465 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | T35OD029981 | Short Term Training in Health Professional Schools | 001 | 2 | NIH | 5/24/2022 | $1,546 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | T35OD029981 | Short Term Training in Health Professional Schools | 000 | 2 | NIH | 4/5/2022 | $64,878 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | U18FD006915 | Method validation for the analysis of cannabinoids in animal specimen and hemp-based animal feed products | 000 | 3 | FDA | 7/20/2022 | $76,000 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01NS112506 | Molecular regulation of LRRK2 in Parkinson's disease | 001 | 3 | NIH | 3/24/2022 | $35,875 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01NS112506 | Molecular regulation of LRRK2 in Parkinson's disease | 000 | 3 | NIH | 12/2/2021 | $322,875 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01EB028848 | Treating Primary aldosteronism-induced hypertension via microwave thermal therapy | 001 | 3 | NIH | 6/27/2022 | $33,070 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01EB028848 | Treating Primary aldosteronism-induced hypertension via microwave thermal therapy | 000 | 3 | NIH | 1/19/2022 | $297,622 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01AI141586 | Discovery of Hsp100-selective inhibitors for targeting multiple microbial pathogens | 000 | 4 | NIH | 7/1/2022 | $328,714 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01GM128659 | Catalytic Asymmetric Oxidation of Alkenes and Alkanes | 001 | 4 | NIH | 7/21/2022 | $29,951 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01GM128659 | Catalytic Asymmetric Oxidation of Alkenes and Alkanes | 000 | 4 | NIH | 2/24/2022 | $269,553 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | U18FD006376 | KSVDL Vet-LRN Veterinary Diagnostic Laboratory Program | 000 | 5 | FDA | 5/24/2022 | $53,200 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01CA218357 | Bronchoscope-guided microwave ablation of early-stage lung tumors | 001 | 5 | NIH | 9/1/2022 | $196,847 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01CA218357 | Bronchoscope-guided microwave ablation of early-stage lung tumors | 002 | 5 | NIH | 9/8/2022 | $4,017 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01MH085739 | Timing, reward processing and choice | 001 | 11 | NIH | 6/28/2022 | $49,684 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01MH085739 | Timing, reward processing and choice | 001 | 11 | NIH | 6/28/2022 | $320,000 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01AI070908 | Vector and Host Contributions to the Regulation of E. Chaffeensis Gene Expression | 000 | 13 | NIH | 6/23/2022 | $536,311 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | R01AI130092 | Small Molecule Protease Inhibitors against MERS-CoV | 000 | 5 | NIH | 5/3/2022 | $728,584 |
| | 2022 | 2022 | KANSAS STATE UNIVERSITY | 2 FAIRCHILD HALL | MANHATTAN | KS | 66506-1100 | RILEY | USA | U18FD007516 | Detection of SARS-CoV-2 and characterization of SARS-CoV-2 S-gene in major companion and food animals | 000 | 2 | FDA | 8/10/2022 | $79,038 |
|
